264 related articles for article (PubMed ID: 30662000)
21. O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer.
Santos SN; Junqueira MS; Francisco G; Vilanova M; Magalhães A; Dias Baruffi M; Chammas R; Harris AL; Reis CA; Bernardes ES
Oncotarget; 2016 Dec; 7(50):83570-83587. PubMed ID: 27835877
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomic analysis of gene expression profiles of stomach carcinoma reveal abnormal expression of mitotic components.
Tong H; Wang J; Chen H; Wang Z; Fan H; Ni Z
Life Sci; 2017 Feb; 170():41-49. PubMed ID: 27923621
[TBL] [Abstract][Full Text] [Related]
23. O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer.
Carvalho S; Oliveira T; Bartels MF; Miyoshi E; Pierce M; Taniguchi N; Carneiro F; Seruca R; Reis CA; Strahl S; Pinho SS
Oncotarget; 2016 Oct; 7(40):65231-65246. PubMed ID: 27533452
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
[TBL] [Abstract][Full Text] [Related]
25. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis.
Keller S; Kneissl J; Grabher-Meier V; Heindl S; Hasenauer J; Maier D; Mattes J; Winter P; Luber B
BMC Cancer; 2017 Dec; 17(1):845. PubMed ID: 29237412
[TBL] [Abstract][Full Text] [Related]
27. RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer.
Song YA; Park YL; Kim KY; Myung E; Chung CY; Cho SB; Lee WS; Jung YD; Kweon SS; Joo YE
Pathol Int; 2012 Feb; 62(2):127-36. PubMed ID: 22243783
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis.
Sentani K; Oue N; Naito Y; Sakamoto N; Anami K; Oo HZ; Uraoka N; Aoyagi K; Sasaki H; Yasui W
Carcinogenesis; 2012 May; 33(5):1081-8. PubMed ID: 22411957
[TBL] [Abstract][Full Text] [Related]
29. miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS
Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111
[TBL] [Abstract][Full Text] [Related]
30. O-glycan recognition and function in mice and human cancers.
Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
[TBL] [Abstract][Full Text] [Related]
31. LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern.
Sun TT; He J; Liang Q; Ren LL; Yan TT; Yu TC; Tang JY; Bao YJ; Hu Y; Lin Y; Sun D; Chen YX; Hong J; Chen H; Zou W; Fang JY
Cancer Discov; 2016 Jul; 6(7):784-801. PubMed ID: 27147598
[TBL] [Abstract][Full Text] [Related]
32. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
33. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
34. MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer.
Canu V; Sacconi A; Lorenzon L; Biagioni F; Lo Sardo F; Diodoro MG; Muti P; Garofalo A; Strano S; D'Errico A; Grazi GL; Cioce M; Blandino G
Oncotarget; 2017 May; 8(18):29540-29557. PubMed ID: 28199974
[TBL] [Abstract][Full Text] [Related]
35. Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer.
Li D; Zhao X; Xiao Y; Mei H; Pu J; Xiang X; Jiao W; Song H; Qu H; Huang K; Zheng L; Tong Q
Oncotarget; 2015 Jun; 6(18):16168-82. PubMed ID: 25965823
[TBL] [Abstract][Full Text] [Related]
36. Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.
Chang HR; Park HS; Ahn YZ; Nam S; Jung HR; Park S; Lee SJ; Balch C; Powis G; Ku JL; Kim YH
BMC Cancer; 2016 Mar; 16():200. PubMed ID: 26955870
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer.
Wang L; Guan X; Gong W; Yao J; Peng Z; Wei D; Wu TT; Huang S; Xie K
Clin Exp Metastasis; 2005; 22(3):205-13. PubMed ID: 16158248
[TBL] [Abstract][Full Text] [Related]
38. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
[TBL] [Abstract][Full Text] [Related]
39. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
[TBL] [Abstract][Full Text] [Related]
40. Alterations in gastric mucin with malignant transformation: novel pathway for mucin synthesis.
Yamashita Y; Chung YS; Horie R; Kannagi R; Sowa M
J Natl Cancer Inst; 1995 Mar; 87(6):441-6. PubMed ID: 7532228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]